top | item 46588010

(no title)

Foivos | 1 month ago

The social stigma in Europe exists, because these drugs are in limited supply. So, if a person who does not really need them is using them, the people who actually need them to stay alive might have difficulty accessing them.

discuss

order

Mashimo|1 month ago

> because these drugs are in limited supply

That's the first time I hear about this. A close friend of mine uses it and she just goes to the pharmacy. Never heard about any problems with supply.

Raed667|1 month ago

this is the remains of the moral outrage that was online and in the media a few years ago when ozympic was first mediatised

vladvasiliu|1 month ago

Where is that? I'm pretty sure in France you can't just walk into a pharmacy and buy it, you need a prescription.

Raed667|1 month ago

that's actually not true, Mounjaro and Wegovy are pretty much meant for weight loss and there is no competition over them for people with diabetes

derektank|1 month ago

Mounjaro is the tirzepatide equivalent to Ozempic (semaglutide) in that it’s prescribed for type 2 diabetes. Wegovy (semaglutide) and Zepbound (tirzepatide) are prescribed for obesity. Otherwise you’re spot on.

dboreham|1 month ago

There is until they're packaged because they're the same drug. Only the label is different.

laurentiurad|1 month ago

you can just order them to your home on any of the websites selling GLP-1. Stop the propaganda inferring that the public healthcare is bad and doesn't allow people to get their medicine.

blell|1 month ago

In Spain you can't. You need to be authorised by a doctor to buy those drugs.

aucisson_masque|1 month ago

Honestly it’s just because people who use them are considered to be weak minded and lazy. That’s all, the supply doesn’t matter.

We have been able to diet for millions of years, our body is pretty good at it, but some people NEED that to diet. Yeah, just like some people can’t be put to work. Everyone know that kind of people who are a burden on society and themselves.

It just happens that this drug is more available in the USA, but with the same availability in Europe, I bet there would be around the same percentage of user.